These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 30338581

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries.
    Pana ZD, Seidel D, Skiada A, Groll AH, Petrikkos G, Cornely OA, Roilides E, Collaborators of Zygomyco.net and/or FungiScope™ Registries*.
    BMC Infect Dis; 2016 Nov 10; 16(1):667. PubMed ID: 27832748
    [Abstract] [Full Text] [Related]

  • 4. Mucormycosis in hematologic patients.
    Pagano L, Offidani M, Fianchi L, Nosari A, Candoni A, Picardi M, Corvatta L, D'Antonio D, Girmenia C, Martino P, Del Favero A, GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) Infection Program.
    Haematologica; 2004 Feb 10; 89(2):207-14. PubMed ID: 15003897
    [Abstract] [Full Text] [Related]

  • 5. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
    Riley TT, Muzny CA, Swiatlo E, Legendre DP.
    Ann Pharmacother; 2016 Sep 10; 50(9):747-57. PubMed ID: 27307416
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A prospective study of mucormycosis in north India: experience from a tertiary care hospital.
    Bala K, Chander J, Handa U, Punia RS, Attri AK.
    Med Mycol; 2015 Apr 10; 53(3):248-57. PubMed ID: 25587084
    [Abstract] [Full Text] [Related]

  • 8. Mucormycosis in paediatric patients: demographics, risk factors and outcome of 12 contemporary cases.
    Däbritz J, Attarbaschi A, Tintelnot K, Kollmar N, Kremens B, von Loewenich FD, Schrod L, Schuster F, Wintergerst U, Weig M, Lehrnbecher T, Groll AH.
    Mycoses; 2011 Nov 10; 54(6):e785-8. PubMed ID: 21623951
    [Abstract] [Full Text] [Related]

  • 9. Invasive cutaneous mucormycosis caused by Absidia corymbifera after allogeneic bone marrow transplantation.
    Jantunen E, Kolho E, Ruutu P, Koukila-Kähkölä P, Virolainen M, Juvonen E, Volin L.
    Bone Marrow Transplant; 1996 Jul 10; 18(1):229-30. PubMed ID: 8832023
    [Abstract] [Full Text] [Related]

  • 10. Mucormycosis in Iran: a systematic review.
    Vaezi A, Moazeni M, Rahimi MT, de Hoog S, Badali H.
    Mycoses; 2016 Jul 10; 59(7):402-15. PubMed ID: 26906121
    [Abstract] [Full Text] [Related]

  • 11. Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates.
    Guinea J, Escribano P, Vena A, Muñoz P, Martínez-Jiménez MDC, Padilla B, Bouza E.
    PLoS One; 2017 Jul 10; 12(6):e0179136. PubMed ID: 28591186
    [Abstract] [Full Text] [Related]

  • 12. Focus on invasive mucormycosis in paediatric haematology oncology patients: a series of 11 cases.
    Phulpin-Weibel A, Rivier A, Leblanc T, Bertrand Y, Chastagner P.
    Mycoses; 2013 May 10; 56(3):236-40. PubMed ID: 23020159
    [Abstract] [Full Text] [Related]

  • 13. Mucormycosis at a tertiary-care center in Mexico. A 35-year retrospective study of 214 cases.
    Bonifaz A, Tirado-Sánchez A, Hernández-Medel ML, Araiza J, Kassack JJ, Del Angel-Arenas T, Moisés-Hernández JF, Paredes-Farrera F, Gómez-Apo E, Treviño-Rangel RJ, González GM.
    Mycoses; 2021 Apr 10; 64(4):372-380. PubMed ID: 33253454
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of zygomycosis cases by pooled analysis method reported from Turkey].
    Zeka AN, Taşbakan M, Pullukçu H, Sipahi OR, Yamazhan T, Arda B.
    Mikrobiyol Bul; 2013 Oct 10; 47(4):708-16. PubMed ID: 24237440
    [Abstract] [Full Text] [Related]

  • 15. First Case of Rhinocerebral Mucormycosis Caused by Lichtheimia ornata, with a Review of Lichtheimia Infections.
    Pan J, Tsui C, Li M, Xiao K, de Hoog GS, Verweij PE, Cao Y, Lu H, Jiang Y.
    Mycopathologia; 2020 Jun 10; 185(3):555-567. PubMed ID: 32388712
    [Abstract] [Full Text] [Related]

  • 16. Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).
    Salmanton-García J, Seidel D, Koehler P, Mellinghoff SC, Herbrecht R, Klimko N, Ráčil Z, Falces-Romero I, Ingram P, Benítez-Peñuela MÁ, Rodríguez JY, Desoubeaux G, Barać A, García-Vidal C, Hoenigl M, Mehta SR, Cheng MP, Klyasova G, Heinz WJ, Iqbal N, Krause R, Ostermann H, Penack O, Schalk E, Sheppard DC, Willinger B, Wisplinghoff H, Vehreschild JJ, Cornely OA, Vehreschild MJGT, FungiScope® ECMM/ISHAM Working Group.
    J Antimicrob Chemother; 2019 Nov 01; 74(11):3315-3327. PubMed ID: 31393591
    [Abstract] [Full Text] [Related]

  • 17. Pediatric Mucormycosis: A 10-Year Systematic Review of Reported Cases and Review of the Literature.
    Otto WR, Pahud BA, Yin DE.
    J Pediatric Infect Dis Soc; 2019 Sep 25; 8(4):342-350. PubMed ID: 31181136
    [Abstract] [Full Text] [Related]

  • 18. Mucormycosis-A clinicoepidemiological review of cases over 10 years.
    Manesh A, Rupali P, Sullivan MO, Mohanraj P, Rupa V, George B, Michael JS.
    Mycoses; 2019 Apr 25; 62(4):391-398. PubMed ID: 30685896
    [Abstract] [Full Text] [Related]

  • 19. Prospective antifungal therapy (PATH) alliance(®) : focus on mucormycosis.
    Kontoyiannis DP, Azie N, Franks B, Horn DL.
    Mycoses; 2014 Apr 25; 57(4):240-6. PubMed ID: 24147728
    [Abstract] [Full Text] [Related]

  • 20. Healthcare burden of probable and proven invasive mucormycosis: a multi-centre cost-of-illness analysis of patients treated in tertiary care hospitals between 2003 and 2016.
    Heimann SM, Vehreschild MJGT, Cornely OA, Heinz WJ, Grüner B, Silling G, Kessel J, Seidel D, Vehreschild JJ.
    J Hosp Infect; 2019 Mar 25; 101(3):339-346. PubMed ID: 30423409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.